CD2 and oral mucositis: For example, Sharma et al. (2012) conducted a randomised clinical trial using Lactobacillus brevis CD2 tablets in patients with HNC receiving chemoradiotherapy and reported a significant reduction in the incidence and severity of oral mucositis [27].